SE460539B - Hybrida humanleukocyt interferoner, dna-sekvens kodande foer dem, vektor innehaallande dna-sekvensen samt farmaceutisk komposition innehaallande hybrida humanleukocytinterferonerna - Google Patents

Hybrida humanleukocyt interferoner, dna-sekvens kodande foer dem, vektor innehaallande dna-sekvensen samt farmaceutisk komposition innehaallande hybrida humanleukocytinterferonerna

Info

Publication number
SE460539B
SE460539B SE8106641A SE8106641A SE460539B SE 460539 B SE460539 B SE 460539B SE 8106641 A SE8106641 A SE 8106641A SE 8106641 A SE8106641 A SE 8106641A SE 460539 B SE460539 B SE 460539B
Authority
SE
Sweden
Prior art keywords
leif
fragment
amino acids
amino acid
trp
Prior art date
Application number
SE8106641A
Other languages
English (en)
Swedish (sv)
Other versions
SE8106641L (sv
Inventor
D V N Goeddel
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SE8106641L publication Critical patent/SE8106641L/
Publication of SE460539B publication Critical patent/SE460539B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8106641A 1980-11-10 1981-11-09 Hybrida humanleukocyt interferoner, dna-sekvens kodande foer dem, vektor innehaallande dna-sekvensen samt farmaceutisk komposition innehaallande hybrida humanleukocytinterferonerna SE460539B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons

Publications (2)

Publication Number Publication Date
SE8106641L SE8106641L (sv) 1982-06-24
SE460539B true SE460539B (sv) 1989-10-23

Family

ID=27394813

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8106641A SE460539B (sv) 1980-11-10 1981-11-09 Hybrida humanleukocyt interferoner, dna-sekvens kodande foer dem, vektor innehaallande dna-sekvensen samt farmaceutisk komposition innehaallande hybrida humanleukocytinterferonerna

Country Status (34)

Country Link
EP (1) EP0051873B1 (es)
JP (1) JP2642291B2 (es)
KR (1) KR920007439B1 (es)
AT (1) ATE46718T1 (es)
AU (1) AU555293B2 (es)
BR (1) BR8107293A (es)
CA (2) CA1212915A (es)
CH (2) CH663032A5 (es)
DE (2) DE3177106D1 (es)
DK (1) DK173590B1 (es)
DO (1) DOP1981004064A (es)
DZ (1) DZ350A1 (es)
ES (2) ES506955A0 (es)
FI (1) FI79550C (es)
FR (1) FR2493867B1 (es)
GB (1) GB2090258B (es)
GR (1) GR81947B (es)
HK (1) HK51685A (es)
IE (1) IE51850B1 (es)
IL (1) IL64243A (es)
IT (1) IT1169276B (es)
KE (1) KE3536A (es)
LU (1) LU83745A1 (es)
MC (1) MC1424A1 (es)
MY (2) MY8700710A (es)
NL (1) NL189092C (es)
NO (1) NO165201C (es)
NZ (1) NZ198906A (es)
PH (1) PH18565A (es)
PL (1) PL233748A1 (es)
PT (1) PT73955B (es)
SE (1) SE460539B (es)
YU (1) YU46597B (es)
ZW (1) ZW26981A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
EP0072541A3 (en) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
EP0085693A1 (en) * 1981-08-14 1983-08-17 A/S Alfred Benzon Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
WO1983002461A1 (en) * 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
WO1984003300A1 (en) * 1983-02-24 1984-08-30 Inst Organicheskogo Sinteza Ak Leukocytic human interferon n and method to obtain it in bacterial cells
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (en) * 1984-08-31 1986-03-12 University Patents, Inc. Hybrid lymphoblastoid-leukocyte human interferons
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4885166A (en) * 1985-06-11 1989-12-05 Ciba-Geigy Corporation Hybrid interferons
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst LUNG SURFACE ACTIVE PROTEINS.
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
EP0830368A1 (en) 1995-06-07 1998-03-25 Genta Incorporated Novel carbamate-based cationic lipids
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
JP2008507298A (ja) 2004-05-19 2008-03-13 マキシジェン， インコーポレイテッド インターフェロンαポリペプチドおよび結合体
KR20080019619A (ko) 2005-05-18 2008-03-04 맥시겐, 인크. 개량된 인터페론-알파 폴리펩티드

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides

Also Published As

Publication number Publication date
NL189092C (nl) 1993-01-04
IL64243A0 (en) 1982-02-28
PL233748A1 (en) 1983-07-18
SE8106641L (sv) 1982-06-24
ES8302778A1 (es) 1983-02-01
AU7730481A (en) 1982-05-20
PT73955B (en) 1983-11-23
PT73955A (en) 1981-12-01
MY8700710A (en) 1987-12-31
CH660743A5 (de) 1987-06-15
JPH07308191A (ja) 1995-11-28
BR8107293A (pt) 1982-08-03
AU555293B2 (en) 1986-09-18
ES8304200A1 (es) 1983-03-01
IT8124967A0 (it) 1981-11-10
DK173590B1 (da) 2001-04-02
FI79550C (fi) 1990-01-10
NO813785L (no) 1982-05-11
MY8800066A (en) 1988-12-31
YU265681A (en) 1984-08-31
EP0051873A2 (en) 1982-05-19
ES512354A0 (es) 1983-03-01
NO165201B (no) 1990-10-01
CA1212915A (en) 1986-10-21
KR920007439B1 (ko) 1992-09-01
NZ198906A (en) 1985-12-13
FR2493867B1 (fr) 1986-06-27
GR81947B (es) 1984-12-12
IT1169276B (it) 1987-05-27
GB2090258A (en) 1982-07-07
YU46597B (sh) 1994-01-20
DZ350A1 (fr) 2004-09-13
EP0051873B1 (en) 1989-09-27
DE3144469A1 (de) 1982-09-02
CA1277616C (en) 1990-12-11
ATE46718T1 (de) 1989-10-15
DOP1981004064A (es) 1988-03-16
HK51685A (en) 1985-07-12
NO165201C (no) 1991-01-16
FR2493867A1 (fr) 1982-05-14
JP2642291B2 (ja) 1997-08-20
IL64243A (en) 1985-11-29
LU83745A1 (de) 1983-09-01
MC1424A1 (fr) 1982-10-18
FI813539L (fi) 1982-05-11
ES506955A0 (es) 1983-02-01
CH663032A5 (de) 1987-11-13
ZW26981A1 (en) 1982-06-02
GB2090258B (en) 1984-05-02
IE812622L (en) 1982-05-10
EP0051873A3 (en) 1982-09-22
NL8105078A (nl) 1982-06-01
KR830007825A (ko) 1983-11-07
PH18565A (en) 1985-08-09
NL189092B (nl) 1992-08-03
KE3536A (en) 1985-06-07
IE51850B1 (en) 1987-04-15
DE3177106D1 (en) 1989-11-02
FI79550B (fi) 1989-09-29
DK494681A (da) 1982-05-11

Similar Documents

Publication Publication Date Title
SE460539B (sv) Hybrida humanleukocyt interferoner, dna-sekvens kodande foer dem, vektor innehaallande dna-sekvensen samt farmaceutisk komposition innehaallande hybrida humanleukocytinterferonerna
US4678751A (en) Hybrid human leukocyte interferons
US4456748A (en) Hybrid human leukocyte interferons
CA1341569C (en) Microbial production of human fibroblast interferon
DK173543B1 (da) Modent humant leukocytinterferon; en bakterie, der kan producere et sådant interferon, og en fremgangsmåde til fremstilling
US6610830B1 (en) Microbial production of mature human leukocyte interferons
EP0152613B1 (en) Novel promoter
EP0041313B1 (en) Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon
JP2865423B2 (ja) サイトカイン型の活性を有するタンパク質、およびこのタンパク質をコード化する組換えｄｎａ、形質転換細胞および微生物
EP0104920B1 (en) Dna sequences, recombinant dna molecules and processes for producing swing growth hormone-like polypeptides
GB2147902A (en) Microbially produced bgh and its use
GB2116980A (en) Human growth hormone variants
HU193512B (en) Process for preparing hybride interferones from human erythrocytes
GB2107718A (en) Human immune interferon
JPH0757190B2 (ja) 酵母中でのポリペプチドの発現
EP0165654B1 (en) Purified interleukin 1
US4801685A (en) Microbial production of mature human leukocyte interferon K and L
EP0215576B1 (en) Cloning and characterization of the bovine interleukin-2 gene
US5122459A (en) Gene encoding biologically active human interleukin 1
US4810645A (en) Microbial production of mature human leukocyte interferon K and L
EP0163603B1 (en) A human t-cell growth factor
KR910009901B1 (ko) 하이브리드 인간 백혈구 인터페론
KR940002537B1 (ko) 인터로이킨-2 폴리펩타이드를 코드화하는 dna 서열, 재조합체 dna, 및 인터로이킨-2의 제조방법
NO165555B (no) Kunstig hybrid humant leukocytt-interferon-kodende dna-sekvens.
NO315003B1 (no) Fremgangsmåte for fremstilling av polypeptid samt DNA-sekvens som koder fordette

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8106641-7

Format of ref document f/p: F